2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Valor IV Pharma Holdings, LLC | 10% Owner | 6,618,033 | Nov 5, 2024 |
| Valor Management L.P. | 10% Owner | 6,618,033 | Nov 5, 2024 |
| Valor Equity Capital IV LLC | 10% Owner | 6,618,033 | Nov 5, 2024 |
| Valor Equity Associates IV L.P. | 10% Owner | 6,618,033 | Nov 5, 2024 |
| Valor Equity Partners IV L.P. | 10% Owner | 6,618,033 | Nov 5, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | Jan 28, 2026 | Kapadia Sandip | CFO | Sell | 26.3 | -3,746 | -13.25% | ✓ | $139.2K |
| Jan 24, 2026 | Jan 26, 2026 | Kapadia Sandip | CFO | Sell | 42.5 | -4,792 | -56.13% | ✗ | $176.4K |
| Jan 24, 2026 | Jan 26, 2026 | Serafin Andrew | CHIEF STRATEGY OFFICER | Sell | 42.5 | -2,242 | -43.96% | ✗ | $82.6K |
| Jan 24, 2026 | Jan 26, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 42.5 | -2,525 | -52.06% | ✗ | $93K |
| Jan 22, 2026 | Jan 26, 2026 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2026 | Jan 26, 2026 | Dayno Jeffrey M. | CEO | Sell | 40.0 | -10,439 | -44.42% | ✗ | $384.4K |
| Jan 15, 2026 | Jan 20, 2026 | Kapadia Sandip | CFO | Sell | 10.0 | -20,961 | -100.00% | ✓ | $752.8K |
| Dec 12, 2025 | Dec 17, 2025 | Dayno Jeffrey M. | CEO | Sell | 5.0 | -25,933 | -100.00% | ✓ | $1M |
| Dec 5, 2025 | Dec 9, 2025 | Kapadia Sandip | CFO | Sell | 7.5 | -20,000 | -100.00% | ✓ | $790.9K |
| Nov 21, 2025 | Nov 25, 2025 | Kapadia Sandip | CFO | Sell | 10.0 | -3,427 | -100.00% | ✓ | $119.9K |
| Sep 30, 2025 | Oct 2, 2025 | Kapadia Sandip | CFO | Sell | 40.0 | -24,039 | -53.42% | ✗ | $662.5K |
| Aug 28, 2025 | Sep 2, 2025 | Valor IV Pharma Holdings, LLC | 10% Owner | Neutral | 27.5 | -6,618,033 | -91.95% | ✗ | - |
| Aug 15, 2025 | Aug 19, 2025 | Kapadia Sandip | CFO | Sell | 7.5 | -21,573 | -100.00% | ✓ | $787.4K |
| May 15, 2025 | May 16, 2025 | Sabater Juan A. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 15, 2025 | May 16, 2025 | Gracias Antonio J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 15, 2025 | May 16, 2025 | Philip Ron M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 15, 2025 | May 16, 2025 | Szyper Linda M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 15, 2025 | May 16, 2025 | Anastasiou Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2025 | May 16, 2025 | Graf R. Mark | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 15, 2025 | May 16, 2025 | Sender Gary | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 1, 2025 | May 9, 2025 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 40.0 | -8,869 | -47.30% | ✗ | $264.8K |
| Apr 7, 2025 | Apr 16, 2025 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 16, 2025 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 2, 2025 | Apr 4, 2025 | Philip Ron M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 4, 2025 | Philip Ron M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 1, 2025 | Apr 3, 2025 | Kapadia Sandip | CFO | Sell | 10.0 | -6,987 | -100.00% | ✓ | $227.4K |
| Mar 29, 2025 | Apr 1, 2025 | Kapadia Sandip | CFO | Sell | 40.0 | -8,014 | -53.43% | ✗ | $266K |
| Mar 3, 2025 | Mar 5, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 10.0 | -4,869 | -100.00% | ✓ | $159.1K |
| Jan 24, 2025 | Jan 28, 2025 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 46.3 | -1,151 | -52.63% | ✗ | $43.7K |
| Jan 24, 2025 | Jan 28, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 7.5 | -15,812 | -70.07% | ✓ | $591.8K |
| Jan 24, 2025 | Jan 28, 2025 | Dayno Jeffrey M. | CEO | Sell | 42.5 | -4,567 | -43.50% | ✗ | $173.6K |
| Jan 24, 2025 | Jan 28, 2025 | Kapadia Sandip | CFO | Sell | 10.0 | -3,812 | -100.00% | ✓ | $145K |
| Jan 24, 2025 | Jan 28, 2025 | Serafin Andrew | CHIEF STRATEGY OFFICER | Sell | 46.3 | -865 | -34.60% | ✗ | $32.9K |
| Jan 21, 2025 | Jan 23, 2025 | Dayno Jeffrey M. | CEO | Sell | 7.5 | -19,293 | -100.00% | ✓ | $774.2K |
| Jan 21, 2025 | Jan 23, 2025 | Kapadia Sandip | CFO | Sell | 5.0 | -25,000 | -100.00% | ✓ | $1M |
| Jan 16, 2025 | Jan 21, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 5.0 | -30,598 | -100.00% | ✓ | $1.1M |
| Jan 15, 2025 | Jan 16, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 7.5 | -10,507 | -100.00% | ✓ | $388.8K |
| Jan 13, 2025 | Jan 15, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 7.5 | -7,180 | -100.00% | ✓ | $265.9K |
| Nov 1, 2024 | Nov 5, 2024 | Valor IV Pharma Holdings, LLC | 10% Owner | Sell | 15.0 | -4,600,000 | -41.01% | ✗ | $139.4M |
| Nov 1, 2024 | Nov 5, 2024 | Marshman Fund Trust II | 10% Owner | Sell | 15.0 | -4,600,000 | -43.19% | ✗ | $139.4M |
| Oct 29, 2024 | Oct 31, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 7.5 | -21,496 | -100.00% | ✓ | $870K |
| Oct 3, 2024 | Oct 7, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 5.0 | -36,357 | -100.00% | ✓ | $1.3M |
| Oct 1, 2024 | Oct 2, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 13.8 | -400 | -100.00% | ✓ | $16.1K |
| Sep 30, 2024 | Oct 2, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 40.0 | -23,643 | -39.41% | ✗ | $945.7K |
| Sep 30, 2024 | Oct 2, 2024 | Kapadia Sandip | CFO | Sell | 37.5 | -32,052 | -53.42% | ✗ | $1.3M |
| Sep 30, 2024 | Oct 1, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 5.0 | -35,846 | -100.00% | ✓ | $1.4M |
| Sep 27, 2024 | Sep 30, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 15.0 | -200 | -100.00% | ✓ | $8K |
| May 29, 2024 | May 31, 2024 | Sender Gary | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2024 | May 31, 2024 | Gracias Antonio J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2024 | May 31, 2024 | Sabater Juan A. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2024 | May 31, 2024 | Graf R. Mark | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2024 | May 31, 2024 | Nielsen Jack | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2024 | May 31, 2024 | Szyper Linda M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2024 | May 31, 2024 | Anastasiou Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 1, 2024 | May 3, 2024 | Budur Kumar | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 29, 2024 | Apr 2, 2024 | Kapadia Sandip | CFO | Sell | 40.0 | -8,013 | -53.42% | ✗ | $269.1K |
| Mar 15, 2024 | Mar 18, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 7.5 | -11,979 | -100.00% | ✓ | $383.3K |
| Mar 8, 2024 | Mar 11, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 15.0 | -194 | -100.00% | ✓ | $6.2K |
| Jan 24, 2024 | Jan 26, 2024 | Budur Kumar | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 26, 2024 | Budur Kumar | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 24, 2024 | Jan 26, 2024 | Dayno Jeffrey M. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Jan 26, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Jan 26, 2024 | Serafin Andrew | CHIEF STRATEGY OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Jan 26, 2024 | Kapadia Sandip | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2023 | Nov 8, 2023 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2023 | Nov 8, 2023 | Kapadia Sandip | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 5, 2023 | Nov 8, 2023 | Anastasiou Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 8, 2023 | Anastasiou Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 26, 2023 | May 31, 2023 | Dayno Jeffrey M. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 26, 2023 | May 30, 2023 | Dayno Jeffrey M. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2023 | May 26, 2023 | Nielsen Jack | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2023 | May 26, 2023 | Sender Gary | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2023 | May 26, 2023 | Graf R. Mark | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2023 | May 26, 2023 | Sabater Juan A. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2023 | May 26, 2023 | Gracias Antonio J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 25, 2023 | May 26, 2023 | Szyper Linda M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 29, 2023 | Mar 31, 2023 | Kapadia Sandip | CFO | Sell | 40.0 | -15,414 | -51.38% | ✗ | $514.2K |
| Dec 14, 2022 | Dec 16, 2022 | Nielsen Jack | Director | Sell | 50.0 | -2,834 | -0.11% | ✓ | $169.9K |
| Dec 12, 2022 | Dec 14, 2022 | Wicki Andreas | Director | Sell | 17.5 | -28,841 | -1.32% | ✗ | $1.7M |
| Dec 7, 2022 | Dec 9, 2022 | Nielsen Jack | Director | Sell | 31.3 | -110,751 | -4.13% | ✓ | $6.7M |
| Dec 5, 2022 | Dec 7, 2022 | Wicki Andreas | Director | Sell | 17.5 | -77,853 | -3.45% | ✗ | $4.8M |
| Dec 2, 2022 | Dec 5, 2022 | Serafin Andrew | CHIEF STRATEGY OFFICER | Sell | 5.0 | -38,000 | -100.00% | ✓ | $2.3M |
| Nov 29, 2022 | Dec 1, 2022 | Nielsen Jack | Director | Sell | 31.3 | -129,652 | -4.61% | ✓ | $7.7M |
| Nov 18, 2022 | Nov 22, 2022 | Nielsen Jack | Director | Sell | 36.3 | -77,600 | -2.68% | ✓ | $4.4M |
| Nov 14, 2022 | Nov 16, 2022 | Wicki Andreas | Director | Sell | 17.5 | -51,278 | -2.22% | ✗ | $3M |
| Nov 11, 2022 | Nov 15, 2022 | Nielsen Jack | Director | Sell | 26.3 | -158,400 | -5.19% | ✓ | $9.1M |
| Nov 8, 2022 | Nov 10, 2022 | Wicki Andreas | Director | Sell | 16.3 | -129,408 | -5.31% | ✗ | $7.6M |
| Nov 2, 2022 | Nov 4, 2022 | Wicki Andreas | Director | Sell | 15.0 | -576,767 | -19.15% | ✗ | $34.1M |
| Nov 3, 2022 | Nov 4, 2022 | Dayno Jeffrey M. | CHIEF MEDICAL OFFICER | Sell | 7.5 | -15,000 | -100.00% | ✓ | $900.3K |
| Nov 1, 2022 | Nov 2, 2022 | Dayno Jeffrey M. | CHIEF MEDICAL OFFICER | Sell | 7.5 | -15,000 | -100.00% | ✓ | $826.6K |
| Oct 3, 2022 | Oct 4, 2022 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 7.5 | -12,173 | -100.00% | ✓ | $543.9K |
| Aug 22, 2022 | Aug 23, 2022 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 5.0 | -28,971 | -100.00% | ✓ | $1.4M |
| Aug 15, 2022 | Aug 16, 2022 | Jacobs John C | CEO | Sell | 5.0 | -40,000 | -100.00% | ✓ | $2M |
| Aug 8, 2022 | Aug 10, 2022 | Wicki Andreas | Director | Sell | 15.0 | -578,552 | -16.11% | ✗ | $31.1M |
| Aug 4, 2022 | Aug 8, 2022 | Nielsen Jack | Director | Sell | 15.0 | -250,000 | -7.58% | ✗ | $13.2M |
| Aug 3, 2022 | Aug 5, 2022 | Wicki Andreas | Director | Sell | 17.5 | -72,586 | -1.98% | ✗ | $3.8M |
| Aug 2, 2022 | Aug 3, 2022 | Nielsen Jack | Director | Sell | 36.3 | -75,117 | -2.23% | ✓ | $4.1M |
| Jul 18, 2022 | Jul 20, 2022 | Nielsen Jack | Director | Sell | 40.0 | -40,087 | -1.17% | ✓ | $2.2M |
| Jul 13, 2022 | Jul 15, 2022 | Nielsen Jack | Director | Sell | 47.5 | -5,773 | -0.17% | ✓ | $317.7K |
| Jul 8, 2022 | Jul 12, 2022 | Nielsen Jack | Director | Sell | 46.3 | -10,768 | -0.31% | ✓ | $592.8K |